DAVE
Dave Inc.
DAVE's fundamentals are strong: revenue grew 41% and its operating margin rose 8 points to 32%. At 22x earnings, it's trading in line with its usual 23x. Analysts expect that strong growth to continue.
DAVE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
DAVE's revenue, profitability, cash flow and balance sheet are all currently healthy.
DAVE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $267 | — |
| Cheap | 18x | $227 | -15% |
| Current | 22x | $267 | — |
| Fair | 23x | $287 | +7.2% |
| Expensive | 58x | $718 | +169% |
Historical ranges are pointers, not guarantees.
DAVE's PE is in its fair range at 22x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
DAVE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for DAVE, with profitability improving.
DAVE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $18.94 | +53% |
| Q3 2026 | $12.41 | +24% |
| Q2 2026 | $15.45 | +316% |
| Q1 2026 | $15.58 | +338% |
| Q4 2025 | $13.53 | +223% |
| Q3 2025 | $10.02 | +220% |
| Q2 2025 | $3.71 | +78% |
| Q1 2025 | $3.56 | +$3.84 |
| Q4 2024 | $4.19 | +$8.26 |
DAVE's earnings per share have climbed steadily: $12.41 over the past year, up 24% from the year before, and higher year over year every quarter since late 2024.
DAVE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $197.7M | +31% |
| Q2 2026 | $170.8M | +30% |
| Q1 2026 | $158.4M | +47% |
| Q4 2025 | $163.7M | +62% |
| Q3 2025 | $150.7M | +63% |
| Q2 2025 | $131.8M | +64% |
| Q1 2025 | $108M | +47% |
| Q4 2024 | $100.8M | +38% |
DAVE's revenue has grown year over year every quarter since early 2022: $198M last quarter, up 31% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | -1.1 points |
| Q2 2026 | 8.6% | -0.1 points |
| Q1 2026 | 44% | +13 points |
| Q4 2025 | 39% | +22 points |
| Q3 2025 | 39% | +38 points |
| Q2 2025 | 8.7% | +3 points |
| Q1 2025 | 31% | -20 points |
| Q4 2024 | 17% | +17 points |
DAVE's operating margin was 38% last quarter, down 1.1 points from the same quarter a year ago.
DAVE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $81.4M | -2.1% |
| Q2 2026 | $68.1M | +0.1% |
| Q1 2026 | $82M | +81% |
| Q4 2025 | $93.2M | +124% |
| Q3 2025 | $83.2M | +125% |
| Q2 2025 | $68.1M | +144% |
| Q1 2025 | $45.2M | +147% |
| Q4 2024 | $41.7M | +167% |
DAVE generated $325M in free cash flow over the past year, up 36% from the year before.
DAVE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +241K shares |
| 1 year | -4.2% | -604K shares |
| 3 years | +16% | +2M shares |
DAVE has 14M diluted shares, down 4.2% from a year ago, with $224M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6M |
| Q2 2026 | $19.1M |
| Q1 2026 | $186.7M |
| Q4 2025 | $11.8M |
| Q3 2025 | $25M |
| Q2 2025 | — |
| Q1 2025 | $6.9M |
| Q4 2023 | — |
DAVE spent $224M buying back its own shares over the past year.
DAVE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.6x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | 0.4x | Very low |
DAVE has more cash than debt.
DAVE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.0 | Neutral |
| Stochastic | 9.7 | Oversold |
DAVE's weekly RSI is 41 (neutral) and its Stochastic is 10 (oversold).
DAVE PE vs Technology Sector
| Metric | DAVE | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 28x | 23% below |
| PE % | 39 | 42 | 3 pts below |
DAVE is trading at 22x earnings, a 23% discount to the Technology sector's median of 28x.
DAVE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $328.1 | 19% below |
| 20 week MA | $354.2 | 25% below |
| 50 week MA | $276.9 | 3.4% below |
| 100 week MA | $220.9 | 21% above |
| 200 week MA | $122.2 | 119% above |
DAVE has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 119% above its 200-week average.
DAVE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $315.5 | $318.7 | +1% |
| 2022 | $318.7 | $9.50 | -97% |
| 2023 | $9.50 | $8.39 | -12% |
| 2024 | $8.39 | $97.8 | +1066% |
| 2025 | $97.8 | $229.2 | +134% |
| 2026 YTD | $229.2 | $267.4 | +17% |
DAVE's yearly returns have swung widely, from +1066% in 2024 to −97% in 2022. It's up 17% so far in 2026.